Lantheus Holdings LNTH
NASDAQ LNTH
$99.97 -0.27 (-0.27%)
At close: Aug 21, 2026 · 4:00 PM EDT

Lantheus Holdings (LNTH) Cash from Financing Activities (2014 - 2026)

Lantheus Holdings (LNTH) posted quarterly Cash from Financing Activities of -$11.6 million for Q1 2026, up 36.2% year-over-year from -$8.5 million in Q1 2025, and up 88.47% quarter-over-quarter from -$100.8 million in Q4 2025.

Lantheus Holdings (LNTH) Cash from Financing Activities (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has reported Cash from Financing Activities for 13 consecutive years, with -$11.6 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash from Financing Activities rose 36.2% year-over-year to -$11.6 million; the TTM figure through Mar 2026 stood at -$310.0 million (down 158.52% YoY), while the FY2025 annual figure was -$316.6 million, down 167.08% from the prior year.
  • Cash from Financing Activities rose to -$11.6 million in Q1 2026 per LNTH's latest filing, from -$100.8 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $317.8 million in Q4 2022 and bottomed at -$103.7 million in Q4 2024.
  • Historically, Cash from Financing Activities has averaged -$8.7 million across 5 years, with a median of -$4.1 million in 2023.
  • Annual changes were most pronounced in 2022 — Cash from Financing Activities soared 15235.24% — and 2025, when it sank 99507.07%.
  • Lantheus Holdings' Cash from Financing Activities stood at $317.8 million in 2022, then sank by 100.14% to -$450000.0 in 2023, then plunged by 22935.33% to -$103.7 million in 2024, then gained by 2.77% to -$100.8 million in 2025, then jumped by 88.47% to -$11.6 million in 2026.
  • Business Quant data shows LNTH's Cash from Financing Activities at -$11.6 million in Q1 2026, -$100.8 million in Q4 2025, and -$99.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -1.00 Mn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -813.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -1.13 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 122.40 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -1.24 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 63.40 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -74.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Lantheus Holdings 6.52 Bn 5.93 Bn 241.86 Mn 4.51 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 4.51 Mn
Jun 30, 2026 4.51 Mn
Mar 31, 2026 -11.62 Mn
Mar 31, 2026 -11.62 Mn
Dec 31, 2025 -100.79 Mn
Dec 31, 2025 -100.79 Mn
Sep 30, 2025 -99.17 Mn
Sep 30, 2025 -99.17 Mn
Jun 30, 2025 -98.41 Mn
Jun 30, 2025 -98.41 Mn
Mar 31, 2025 -18.22 Mn
Mar 31, 2025 -18.22 Mn
Dec 31, 2024 -103.66 Mn
Dec 31, 2024 -103.66 Mn
Sep 30, 2024 1.87 Mn
Sep 30, 2024 1.87 Mn
Jun 30, 2024 99,000.00
Jun 30, 2024 99,000.00
Mar 31, 2024 -16.85 Mn
Mar 31, 2024 -16.85 Mn